{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:12:50Z","timestamp":1790485970095,"version":"4.1.0"},"reference-count":73,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T00:00:00Z","timestamp":1401235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J cachexia sarcopenia muscle"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:sec><jats:label\/><jats:p>The two most common muscle wasting diseases in adults are sarcopenia and cachexia. Despite differences in their pathophysiology, it is believed that both conditions are likely to respond to drugs that increase muscle mass and muscle strength. The current gold standard in this regard is exercise training. This article provides an overview of candidate drugs to treat muscle wasting disease that are available or in development. Drugs highlighted here include ghrelin agonists, selective androgen receptor molecules, megestrol acetate, activin receptor antagonists, espindolol, and fast skeletal muscle troponin inhibitors.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s13539-014-0149-7","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T11:03:58Z","timestamp":1401188638000},"page":"83-87","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Are we closer to having drugs to treat muscle wasting disease?"],"prefix":"10.1002","volume":"5","author":[{"given":"John E.","family":"Morley","sequence":"first","affiliation":[{"name":"Divisions of Geriatric Medicine and Endocrinology Saint Louis University School of Medicine  1402 S. Grand Blvd., M238 63104 St. Louis MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"Applied Cachexia Research, Department of Cardiology Charit\u00e9 Medical School  Campus Virchow\u2010Klinikum Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"Applied Cachexia Research, Department of Cardiology Charit\u00e9 Medical School  Campus Virchow\u2010Klinikum Berlin"},{"name":"Department of Innovative Clinical Trials University Medical Centre G\u00f6ttingen  G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,28]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-013-0105-y"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-012-0089-z"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.03.022"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afq034"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2011.04.014"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2011.01.003"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.03.019"},{"key":"e_1_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-013-0106-x"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2011.07.004"},{"key":"e_1_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161207782794149"},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2010.02.004"},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-009-0009-x"},{"key":"e_1_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"e_1_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-012-0067-5"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.04.008"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2011.08.005"},{"key":"e_1_2_2_18_1","article-title":"Exercise training for people following lung resection for non\u2010small cell lung cancer \u2013 a Cochrane systematic review","author":"Cavalheri V","journal-title":"Cancer Treat Rev 2013"},{"key":"e_1_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-012-0096-0"},{"key":"e_1_2_2_20_1","volume-title":"Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults","author":"Fragala MS"},{"key":"e_1_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00310"},{"key":"e_1_2_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2012.07.005"},{"key":"e_1_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.05.021"},{"issue":"2","key":"e_1_2_2_24_1","article-title":"Protein and energy supplementation in elderly people at risk from malnutrition","author":"Milne AC","journal-title":"Cochrane Database Syst Rev 2009"},{"key":"e_1_2_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2009.12.083"},{"key":"e_1_2_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-010-0008-0"},{"key":"e_1_2_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2010.12.005"},{"key":"e_1_2_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(03)00160-8"},{"key":"e_1_2_2_29_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2013.727390"},{"key":"e_1_2_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2011.09.016"},{"key":"e_1_2_2_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0632"},{"key":"e_1_2_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2010.10.004"},{"key":"e_1_2_2_33_1","first-page":"334","article-title":"Efficacy and safety results from a phase II study of anamorelin HC21, a ghrelin receptor agonist, in NSCLC patients","volume":"4","author":"Temel J","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2010.02.012"},{"key":"e_1_2_2_35_1","first-page":"335","article-title":"Phase II study of OHR\/AVR 118 in anorexia\u2013cachexia","volume":"4","author":"Chasen M","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_2_36_1","article-title":"Megestrol acetate for treatment of anorexia\u2010cachexia syndrome","volume":"3","author":"Ruiz Garcia V","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_2_37_1","first-page":"191","article-title":"Treating malnutrition with megestrol acetate: literature review and review of our experience","volume":"6","author":"Karcic E","year":"2002","journal-title":"J Nutr Health Aging"},{"key":"e_1_2_2_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000346446"},{"key":"e_1_2_2_39_1","doi-asserted-by":"crossref","unstructured":"Cuvelier GD Baker TJ Peddi EF Casey LM Lambert PJ Distefano DS et al. A randomized double\u2010blind placebo\u2010controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and\/or cancer therapy. Pediatr Blood Cancer 2013 in press. doi: 10.1002\/pbc.24828.","DOI":"10.1002\/pbc.24828"},{"key":"e_1_2_2_40_1","doi-asserted-by":"publisher","DOI":"10.2147\/nano.2006.1.4.411"},{"key":"e_1_2_2_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.2.567"},{"key":"e_1_2_2_42_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161212802884708"},{"key":"e_1_2_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2010.11.012"},{"key":"e_1_2_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.08.033"},{"key":"e_1_2_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(00)00192-4"},{"key":"e_1_2_2_46_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1251"},{"key":"e_1_2_2_47_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1933"},{"key":"e_1_2_2_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2010.02865.x"},{"key":"e_1_2_2_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glr100"},{"key":"e_1_2_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.078"},{"key":"e_1_2_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.090"},{"key":"e_1_2_2_52_1","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2008.26538"},{"key":"e_1_2_2_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0034-6"},{"key":"e_1_2_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70055-X"},{"key":"e_1_2_2_55_1","first-page":"68","article-title":"Enobasarm, a selective androgen receptor modulator, increases lean body mass in advanced non\u2010small cell lung cancer patients in two pivotal, international phase 3 trials","volume":"4","author":"Steiner MS","year":"2013","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_2_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0035-5"},{"key":"e_1_2_2_57_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161209789105045"},{"key":"e_1_2_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.08.004"},{"key":"e_1_2_2_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23539"},{"key":"e_1_2_2_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000434671.77891.9a"},{"key":"e_1_2_2_61_1","unstructured":"Rooks D. Targeting myostatin and activin receptors. Abstracts 7th Cachexia Conference. Kobe 2013 p.49."},{"key":"e_1_2_2_62_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.061339"},{"key":"e_1_2_2_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/heart.88.4.373"},{"key":"e_1_2_2_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afq071"},{"key":"e_1_2_2_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0046-2"},{"key":"e_1_2_2_66_1","unstructured":"Coats AJS. Novel beta blockers. Abstracts 7th Cachexia Conference. Kobe 2013 p.51."},{"key":"e_1_2_2_67_1","unstructured":"Malik F. Fast skeletal muscle troponin activators and their application to disease\u2010preclinical characterization. Abstracts 7th Cachexia Conference. Kobe 2013 p.50."},{"key":"e_1_2_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.11.037"},{"key":"e_1_2_2_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05619.x"},{"key":"e_1_2_2_70_1","unstructured":"Chen YF. The mitochondrial contribution to muscle atrophy in aging and disease. Abstracts 7th Cachexia Conference. Kobe 2013 p.37."},{"key":"e_1_2_2_71_1","doi-asserted-by":"crossref","unstructured":"Sabbah MN. Long\u2010term therapy with Bendavia (MTP\u2010131) a novel mitochondria\u2010targeting peptide normalizes skeletal muscle fiber type composition in dogs with chronic heart failure. Abstracts 7th Cachexia Conference. Kobe 2013 p.54.","DOI":"10.1016\/j.mito.2013.07.039"},{"key":"e_1_2_2_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-010-0014-2"},{"key":"e_1_2_2_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0025-7"},{"key":"e_1_2_2_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0135-0"}],"container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1007%2Fs13539-014-0149-7","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s13539-014-0149-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T02:45:17Z","timestamp":1698461117000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s13539-014-0149-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,28]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1007\/s13539-014-0149-7"],"URL":"https:\/\/doi.org\/10.1007\/s13539-014-0149-7","archive":["Portico"],"relation":{},"ISSN":["2190-5991","2190-6009"],"issn-type":[{"value":"2190-5991","type":"print"},{"value":"2190-6009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,28]]},"assertion":[{"value":"2014-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}